Meanwhile, it is worth mentioning that we used a non-diabetic rat model of myocardial I/R injury, so the results we obtained may provide experimental evidence for SGLT2 inhibitor therapies for non-T2DM patients with acute coronary syndrome. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.